DermiSense, Inc. is focused on revolutionizing clinical chemistry by developing a flexible and biocompatible microneedle technology to extract dermal interstitial fluid. This innovative approach aims to replace conventional blood tests with less invasive and more accessible diagnostic methods, offering pain-free solutions for diagnostics. DermiSense envisions a future where healthcare costs are significantly reduced, and diagnostics are quick, affordable, and pain-free, benefiting people in remote areas and those with a fear of needles. The company's core values include a commitment to quality, collaborative dialogue, follow-through, and teamwork, ensuring reliable and effective technology for crucial health decisions.